Details for New Drug Application (NDA): 218531
✉ Email this page to a colleague
The generic ingredient in ENALAPRIL MALEATE is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
Summary for 218531
| Tradename: | ENALAPRIL MALEATE |
| Applicant: | Unique Pharm |
| Ingredient: | enalapril maleate |
| Patents: | 0 |
Pharmacology for NDA: 218531
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Decreased Blood Pressure |
Medical Subject Heading (MeSH) Categories for 218531
Suppliers and Packaging for NDA: 218531
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 218531 | ANDA | Rising Pharma Holdings, Inc. | 64980-685 | 64980-685-01 | 100 TABLET in 1 BOTTLE (64980-685-01) |
| ENALAPRIL MALEATE | enalapril maleate | TABLET;ORAL | 218531 | ANDA | Rising Pharma Holdings, Inc. | 64980-685 | 64980-685-10 | 1000 TABLET in 1 BOTTLE (64980-685-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Sep 19, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Sep 19, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Sep 19, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
